Diabetes (DM) is a group of metabolic disorders characterized by hyperglycemia resulting from defects in insulin secretion and/ or insulin action. It can be classified into; type 1 (T1DM) Type 2 DM, type 2 (T2DM), gestational diabetes and other specific types of diabetes. Diabetes is the most common pre-existing medical condition complicating pregnancy. Insulin resistance is associated with both type two diabetes and dislypedemia. This study aims to evaluate the changes in the homeostasis model assessment of insulin resistance (HOMA- IR) and indices of atherogenic lipid profile parameters in pregnant diabetic rats after the administration of Rosiglitazone and /or alkaloid lupine extract. Blood glucose, hemoglobin content (Hb), lipid profile, insulin and glucagon concentrations were investigated at 20th day of gestation. The results revealed the improvement of HOMA-IR and The control of the hyperglycemic status in all treated group. Also, there are an increase in insulin concentration, and a decrease in glucagon concentration in all treated groups, in comparison to, STZ group. Meanwhile, it showed alternation in the atherogenic profile in Rosiglitazone treated groups, in comparison to, lupin treated groups. The correlations among (HOMA-IR and HDL), (AIP and LDL) and (glucose and Hb) were observed in our study at (r = 0.594, p< 0.01), (r = 0.690, p< 0.01), and (r = 0.811, p< 0.01) respectively. The usage of lupine alkaloids to treating type two diabetes during the pregnancy is more favorable to avoid Rosiglitazone side effects. More studies are needed to explore the effect of Rosiglitazone on lipids and cardiovascular risk. |
